Correlation Between Alto Neuroscience, and GT Biopharma
Can any of the company-specific risk be diversified away by investing in both Alto Neuroscience, and GT Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alto Neuroscience, and GT Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alto Neuroscience, and GT Biopharma, you can compare the effects of market volatilities on Alto Neuroscience, and GT Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alto Neuroscience, with a short position of GT Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alto Neuroscience, and GT Biopharma.
Diversification Opportunities for Alto Neuroscience, and GT Biopharma
-0.85 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Alto and GTBP is -0.85. Overlapping area represents the amount of risk that can be diversified away by holding Alto Neuroscience, and GT Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GT Biopharma and Alto Neuroscience, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alto Neuroscience, are associated (or correlated) with GT Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GT Biopharma has no effect on the direction of Alto Neuroscience, i.e., Alto Neuroscience, and GT Biopharma go up and down completely randomly.
Pair Corralation between Alto Neuroscience, and GT Biopharma
Given the investment horizon of 90 days Alto Neuroscience, is expected to under-perform the GT Biopharma. But the stock apears to be less risky and, when comparing its historical volatility, Alto Neuroscience, is 1.36 times less risky than GT Biopharma. The stock trades about -0.18 of its potential returns per unit of risk. The GT Biopharma is currently generating about -0.08 of returns per unit of risk over similar time horizon. If you would invest 306.00 in GT Biopharma on September 13, 2024 and sell it today you would lose (32.00) from holding GT Biopharma or give up 10.46% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Alto Neuroscience, vs. GT Biopharma
Performance |
| Timeline |
| Alto Neuroscience, |
| GT Biopharma |
Alto Neuroscience, and GT Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Alto Neuroscience, and GT Biopharma
The main advantage of trading using opposite Alto Neuroscience, and GT Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alto Neuroscience, position performs unexpectedly, GT Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GT Biopharma will offset losses from the drop in GT Biopharma's long position.| Alto Neuroscience, vs. Emergent Biosolutions | Alto Neuroscience, vs. Bausch Health Companies | Alto Neuroscience, vs. Neurocrine Biosciences | Alto Neuroscience, vs. Teva Pharma Industries |
| GT Biopharma vs. Allarity Therapeutics | GT Biopharma vs. Neurobo Pharmaceuticals | GT Biopharma vs. Virax Biolabs Group | GT Biopharma vs. Quoin Pharmaceuticals Ltd |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Complementary Tools
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |